Concord Biotech Limited
Mainboard₹14,820 / 20 Shares
Concord Biotech Limited IPO Details
The Concord Biotech Limited IPO price band is set between ₹705-741 per equity share, with a face value of ₹1 per share. The issue is managed by Link Intime India Private Limited, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 4 Aug, 2023 and closes on 8 Aug, 2023. Investors can check the allotment status on 11 Aug, 2023, while the listing date is tentatively scheduled for 18 Aug, 2023.
The total issue size is Offer for Sale : 20,925,652 shares, aggregating up to ₹1,551.00 Cr. Stay tuned for the latest Concord Biotech Limited IPO review and GMP updates.
Concord Biotech Limited IPO Review, Rating & Analysis
Concord Biotech Limited IPO Review
NO REVIEWConcord Biotech Limited IPO Rating
Concord Biotech Limited IPO Highlights
IPO Date
Aug 4, 2023 - Aug 8, 2023
Listing Date
18 Aug, 2023
Face Value
₹1 Per Equity Share
Price Band
₹705-741 per equity share
Lot Size
20 Shares
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE, NSE
Concord Biotech Limited IPO Lot Size
The minimum market lot for Concord Biotech Limited IPO is 20 shares with an application amount of ₹14,820. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,820 |
| Retail (Max) | 13 | 260 | ₹1,92,660 |
| S-HNI (Min) | 14 | 280 | ₹2,07,480 |
| S-HNI (Max) | 67 | 1340 | ₹9,92,940 |
| B-HNI (Min) | 68 | 1360 | ₹10,07,760 |
Concord Biotech Limited IPO Timeline
Issue Price
₹705-741 per equity shareFace Value
₹1 Per Equity ShareListing at Group
BSE, NSERegistrar
Link Intime India Private LimitedLead Manager
Kotak Mahindra Capital Company LimitedCitigroup Global Markets India Private LimitedJefferies India Private LimitedIssue Size
Offer for Sale : 20,925,652 shares(aggregating up to ₹1,551.00 Cr)Concord Biotech Limited IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 23 | 1513.98 | 888.48 | 240.08 | - | - | - |
| 31 Mar 22 | 1312.80 | 736.35 | 174.93 | - | - | - |
| 31 Mar 21 | 1182.55 | 630.75 | 234.89 | - | - | - |
All values are in ₹ Cr.
Promoters & Share Holding
Promoter(s) Name
- Mr. Sudhir Vaid
- Mr. Ankur Vaid
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 44.08% | 44.08% |
About Company
Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.
The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.
Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Concord Biotech Limited IPO Subscription Details
| As on | QIB/NII | Retail | Total |
|---|
3.45 times
Frequently Asked Questions about Concord Biotech Limited IPO
When will Concord Biotech Limited IPO open for subscription?
The Concord Biotech Limited IPO opens on 4 Aug, 2023 and closes on 8 Aug, 2023.
What is the investors portion for Concord Biotech Limited IPO?
The investors' portion for QIB is , NII is N/A, and Retail is .
How to apply for Concord Biotech Limited IPO?
You can apply for Concord Biotech Limited IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Concord Biotech Limited IPO?
The issue size of Concord Biotech Limited IPO is approx ₹Offer for Sale : 20,925,652 shares(aggregating up to ₹1,551.00 Cr) crores.
What is the price band of Concord Biotech Limited IPO?
The price band for Concord Biotech Limited IPO is ₹705 to ₹741 per equity share.
What is the lot size of Concord Biotech Limited IPO?
The minimum bid (lot size) for Concord Biotech Limited IPO is N/A shares with an investment of approx ₹14,820 .
What is the allotment date of Concord Biotech Limited IPO?
The allotment date for Concord Biotech Limited IPO is 11 Aug, 2023.
What is the listing date of Concord Biotech Limited IPO?
The listing date for Concord Biotech Limited IPO is expected to be 18 Aug, 2023.
What is the GMP of Concord Biotech Limited IPO?
The latest Grey Market Premium (GMP) for Concord Biotech Limited IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.